Skip to main content
. 2021 Jun 3;14:2329–2341. doi: 10.2147/IJGM.S314911

Figure 5.

Figure 5

Restrict overall survival analysis on GNG11 mRNA expression in patients with ovarian serous cystadenocarcinoma. (A) Tumor grade; (B) cancer stage; (C) TP53 mutation status.